IGR Meeting : Improving Adoptive Cell Therapy

Adoptive cell therapy, particularly CAR T-cell therapy, has marked a revolutionary milestone in the treatment of hematological malignancies and is now making strides in the realm of auto-immune diseases. However, for solid tumors, there remains a substantial path ahead.

This congress will delve into the critical aspects of optimizing adoptive cell therapy;
– The host conditions for greater efficacy of adoptive cell therapy.
– Focus on T-cell engineering, novel targets for CAR T-cell therapy.

Date : 30-31 May

Location : the Cordeliers Research Centre.

The meeting is designed to provide networking between clinicians, scientists from academic and industrial parterns in the field of cell therapies.

For those keen on diving deeper into biomanufacturing and gene delivery, we invite you to schedule a meeting with :

• Christine Duthoit, Chief Innovation Officer
• Alexandra Iché, Gene Engineering Project Manager
• Antoinette Crooke, Business Developper
• Patricia Canivenq, R&D Product Manager

Don’t miss this opportunity to be part of the dialogue driving forward the future of advanced therapies.

To register at this meeting : https://www.eventcreate.com/e/improving-adoptive-cell-therapy